Delivery Order SPE2DB22D3301-SPE2DB24FY4SM
Award Date 4/15/24
Potential Completion Date 4/16/24
Potential Value $5.7K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a $1,451.40 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of the pharmaceutical product Trulicity 0.75 mg/0.5 ml pen. This order is placed under Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $5,451.51 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of Trulicity 0.75 mg/0.5 ml pen 0.5 ml, a specialty pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,038.24 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide the pharmaceutical product Trulicity 0.75 mg/0.5 ml pen 0.5 ml. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that AmerisourceBergen Drug Corp holds with DLA to deliver a comprehensive range of pharmaceutical products and medical...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp's Corporate Office Division a $1,338.75 firm fixed-price Delivery Order contract for the supply of Trulicity 1.5 mg/0.5 ml pens. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed-price delivery order contract valued at $2,902.80 to provide Trulicity 4.5 mg/0.5 ml pen 0.5 ml. This award is part of Amerisourcebergen Drug Corp's larger indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 to deliver pharmaceutical products and medical supplies in support of U.S. military treatment programs and...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $11,611.20 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of Trulicity 0.75 mg/0.5 ml pens to support DLA's medical mission. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $4,354.20 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of Trulicity 1.5 mg/0.5 ml pen medication. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a wide range of pharmaceutical products and medical supplies to support...
- The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $1,579.29 to Amerisourcebergen Drug Corp, Corporate Office Division, for the supply of Trulicity 4.5 mg/0.5 ml pens. This contract is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA...
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. The contract, valued at $1,451.40, is for the supply of Trulicity 1.5 mg/0.5 ml pens to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,198,730 units of the medication Trulicity 1.5 mg/0.5 ml pen. The contract, valued at $3,047.94, has an ultimate completion date of April 9, 2024. Amerisourcebergen Drug Corp, as the prime contractor, will provide these pharmaceutical products to DLA Troop Support Medical facilities in support of...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB24FY4SMDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract valued at $5,727.54 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is to provide the pharmaceutical product Trulicity 1.5 mg/0.5 ml pen, 0.5 ml. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025, which enables the DLA to efficiently procure a comprehensive range of pharmaceutical and medical supplies for the U.S. Armed Forces. The contract does not have a set-aside designation.
Generated 7/15/24, 6:35 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.7k | 4/15/24 |